Large-scale cancer proteomics study profiles protein changes in response to drug treatments

Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of Texas MD Anderson Cancer Center have generated a valuable resource to aid in predicting drug sensitivity, to understand therapeutic resistance mechanisms and to identify optimal combination treatment strategies. Their findings, published today in Cancer Cell, […]

Continue Reading